Olga Blau

3.4k total citations · 1 hit paper
39 papers, 1.9k citations indexed

About

Olga Blau is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, Olga Blau has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 16 papers in Molecular Biology and 12 papers in Cancer Research. Recurrent topics in Olga Blau's work include Acute Myeloid Leukemia Research (23 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Cancer Genomics and Diagnostics (8 papers). Olga Blau is often cited by papers focused on Acute Myeloid Leukemia Research (23 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Cancer Genomics and Diagnostics (8 papers). Olga Blau collaborates with scholars based in Germany, United States and Russia. Olga Blau's co-authors include Igor Wolfgang Blau, Eckhard Thiel, Wolf K. Hofmann, Daniel Nowak, Jörg Hofmann, Susanne Ganepola, Gero Hütter, Thomas Schneider, Maximilian Mossner and Kristina Allers and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Olga Blau

35 papers receiving 1.9k citations

Hit Papers

Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cel... 2009 2026 2014 2020 2009 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Blau Germany 14 851 645 551 513 504 39 1.9k
Maximilian Mossner Germany 14 848 1.0× 623 1.0× 244 0.4× 507 1.0× 384 0.8× 33 1.7k
Phuong L. Nguyen United States 18 1.3k 1.5× 415 0.6× 270 0.5× 594 1.2× 980 1.9× 67 2.4k
Kathrin Rieger Germany 16 388 0.5× 291 0.5× 518 0.9× 215 0.4× 448 0.9× 32 1.4k
Maria Bettinotti United States 25 675 0.8× 404 0.6× 305 0.6× 311 0.6× 1.4k 2.9× 52 2.2k
Lela Kardava United States 23 325 0.4× 462 0.7× 168 0.3× 232 0.5× 1.2k 2.4× 36 2.0k
Nobuaki Shimizu Japan 20 343 0.4× 487 0.8× 287 0.5× 194 0.4× 310 0.6× 77 1.6k
Elena Pérez United States 19 165 0.2× 353 0.5× 320 0.6× 269 0.5× 1.1k 2.2× 49 1.8k
M Courcoul France 15 401 0.5× 251 0.4× 200 0.4× 274 0.5× 362 0.7× 26 952
Mohammed Asmal United States 19 246 0.3× 578 0.9× 135 0.2× 193 0.4× 313 0.6× 41 1.1k
Pamela G. Kidd United States 21 216 0.3× 248 0.4× 316 0.6× 252 0.5× 374 0.7× 43 1.5k

Countries citing papers authored by Olga Blau

Since Specialization
Citations

This map shows the geographic impact of Olga Blau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Blau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Blau more than expected).

Fields of papers citing papers by Olga Blau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Blau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Blau. The network helps show where Olga Blau may publish in the future.

Co-authorship network of co-authors of Olga Blau

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Blau. A scholar is included among the top collaborators of Olga Blau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Blau. Olga Blau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blau, Igor Wolfgang, Olga Blau, Laura Rocchi, et al.. (2024). In vitro testing of drug response in primary multiple myeloma cells using a microwell-based technology. Leukemia Research. 147. 107599–107599.
2.
Ihlow, Jana, Livius Penter, Lam Vuong, et al.. (2024). Diagnosing recipient- vs. donor-derived posttransplant myelodysplastic neoplasm via targeted single-cell mutational profiling. Med. 6(4). 100548–100548.
3.
4.
Dai, Hao, Olaf Penack, Igor Wolfgang Blau, et al.. (2021). Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD. Blood Cancer Journal. 11(2). 42–42. 6 indexed citations
6.
Schlickeiser, Stephan, Mathias Streitz, Katrin Vogt, et al.. (2019). Long-Term Signs of T Cell and Myeloid Cell Activation After Intestinal Transplantation With Cellular Rejections Contributing to Further Increase of CD16+ Cell Subsets. Frontiers in Immunology. 10. 866–866. 1 indexed citations
7.
Blau, Olga, et al.. (2017). The Warburg effect in Multiple Myeloma and its microenvironment. Medical Research Archives. 5(9). 9 indexed citations
8.
Blau, Olga. (2016). Genetic Mutations in Acute Myeloid Leukemia. Clinical oncohematology. 9(3). 245–256. 1 indexed citations
9.
Blau, Igor Wolfgang, et al.. (2015). Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia. Journal of Experimental & Clinical Cancer Research. 34(1). 55–55. 11 indexed citations
10.
Nogai, Axel, Olga Blau, Martin Schmidt‐Hieber, et al.. (2015). Multiple myeloma cells modify VEGF/IL‐6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR‐223. Molecular Carcinogenesis. 55(12). 1927–1939. 31 indexed citations
11.
Blau, Igor Wolfgang, et al.. (2014). Comparative examination of various PCR-based methods for DNMT3A and IDH1/2 mutations identification in acute myeloid leukemia. Journal of Experimental & Clinical Cancer Research. 33(1). 44–44. 15 indexed citations
12.
Ostendorf, Benjamin N., Olga Blau, Lutz Uharek, Igor Wolfgang Blau, & Olaf Penack. (2014). Association between low uric acid levels and acute graft-versus-host disease. Annals of Hematology. 94(1). 139–144. 14 indexed citations
13.
Blau, Olga. (2013). Chimerism following allogeneic hematopoietic stem cell transplantation. SHILAP Revista de lepidopterología. 6(1). 34–39.
14.
Blau, Olga, et al.. (2012). Molecular analysis of differentFLT3-ITD mutations in acute myeloid leukemia. Leukemia & lymphoma. 54(1). 145–152. 29 indexed citations
16.
Schmidt‐Hieber, Martin, Igor Wolfgang Blau, Gregor Richter, et al.. (2010). Cytogenetic studies in acute leukemia patients relapsing after allogeneic stem cell transplantation. Cancer Genetics and Cytogenetics. 198(2). 135–143. 13 indexed citations
17.
Heesch, Sandra, Nicola Goekbuget, Andrea Stroux, et al.. (2010). Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia. Haematologica. 95(6). 942–949. 36 indexed citations
18.
Hütter, Gero, Daniel Nowak, Maximilian Mossner, et al.. (2009). Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation. New England Journal of Medicine. 360(7). 692–698. 1250 indexed citations breakdown →
19.
Blau, Olga, Wolf‐Karsten Hofmann, Claudia D. Baldus, et al.. (2007). Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia. Experimental Hematology. 35(2). 221–229. 128 indexed citations
20.
Blau, Igor Wolfgang, Martin Schmidt‐Hieber, Wolfgang Knauf, et al.. (2007). Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation. Annals of Hematology. 86(8). 583–589. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026